找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Evidence-based Therapy in Vascular Surgery; E. Sebastian Debus,Reinhart T. Grundmann Book 20171st edition The Editor(s) (if applicable) an

[復(fù)制鏈接]
樓主: 變更
11#
發(fā)表于 2025-3-23 11:50:19 | 只看該作者
12#
發(fā)表于 2025-3-23 14:08:34 | 只看該作者
13#
發(fā)表于 2025-3-23 19:01:10 | 只看該作者
14#
發(fā)表于 2025-3-23 23:11:04 | 只看該作者
https://doi.org/10.1007/978-981-13-8149-2e are no evidence-based recommendations showing that one method is more advantageous than the other. The type of revascularization must be chosen with regard to patient comorbidity, degree of ulceration, extent of the arterial lesion, and available expertise of the center. Diabetic foot osteomyeliti
15#
發(fā)表于 2025-3-24 03:43:01 | 只看該作者
Andrzej Zi?bik,Krzysztof Hoinka be considered as an alternative to CEA in high-volume centres with documented death or stroke rate <3% in asymptomatic patients, and <6% in symptomatic patients, respectively. Especially, women younger than 75 years of age, patients with contralateral occlusion and restenosis have no increased risk with CAS compared to CEA.
16#
發(fā)表于 2025-3-24 07:08:40 | 只看該作者
https://doi.org/10.1007/978-3-319-48220-0are outlined. For the uncomplicated forms a conservative approach is recommended, complicated forms require endovascular stent grafting or an open surgical procedure. Although randomized studies are missing, the results of retrospective case series and register-related studies favor the endovascular treatment over open surgery.
17#
發(fā)表于 2025-3-24 11:56:55 | 只看該作者
18#
發(fā)表于 2025-3-24 16:29:07 | 只看該作者
19#
發(fā)表于 2025-3-24 20:02:02 | 只看該作者
André Dorsman,Wim Westerman,John L. Simpson Renal artery angioplasty and stenting may be considered for patients with RAS and complicated, uncontrolled hypertension. Surgery remains the primary approach for patients with complex lesions of arterial bifurcation or branches, stenoses associated with complex aneurysms, or following PTA failure.
20#
發(fā)表于 2025-3-24 23:47:25 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 08:30
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
清水河县| 杨浦区| 巴林右旗| 青海省| 比如县| 雷州市| 大连市| 东宁县| 勃利县| 仙居县| 江山市| 临汾市| 沧源| 河间市| 赫章县| 彭山县| 三门峡市| 南平市| 彰化县| 衡东县| 卢湾区| 渭源县| 韶关市| 巴东县| 平泉县| 永德县| 永安市| 喜德县| 休宁县| 越西县| 灵武市| 长汀县| 靖西县| 英吉沙县| 红安县| 盐津县| 遵义市| 宜川县| 三江| 壶关县| 旌德县|